By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sistemic and Roslin Cells today announced a memorandum of understanding to promote technologies to standardize the manufacture of stem cells for use in cell therapy and drug development screening.

Financial and other terms of the MOU were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.